Skip to content

Clinical trials

Hepatitis C, Chronic trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis C, Chronic Country / region: United States Clear all

245 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20015
20022
20038
200411
200511
20067
200718
200819
200912
201012
201133
201227
201315
20149
20158
201611
201715
20186
20191
20205
20211
20222
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed208
Terminated18
Unknown status10
Withdrawn6
Active, not recruiting2
No longer available1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche32
Gilead Sciences24
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)17
Bristol-Myers Squibb11
Boehringer Ingelheim9
AbbVie7
Vertex Pharmaceuticals Incorporated7
GlaxoSmithKline6
University of North Carolina, Chapel Hill6
Debiopharm International SA5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis C, Chronic245
Hepatitis C109
Hepatitis19
Liver Diseases19
Fibrosis15
Hepatitis, Chronic10
Acquired Immunodeficiency Syndrome9
Virus Diseases8
Infections6
Digestive System Diseases5

Trials

Showing 26 to 50 of 245. Each trial links to its page on Pharma Observatory.

145 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.